Clinical experience with myleran in the treatment of leukemia
Suarez, R.M.; Suarez, R.M.; Sabater, J.; Buso, R.
Boletin de la Asociacion Medica de Puerto Rico 47(3): 93-102
1955
ISSN/ISBN: 0004-4849 PMID: 14378328 Document Number: 701754
Document emailed within 1 workday
Related Documents
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370Dunjic, A.; Cuvelier, A.M. 1973: Survival of rat bone marrow cells after treatment with myleran and endoxan Experimental Hematology 1(1): 11-21
Sun, G.L.; Ouyang, R.R.; Chen, S.J.; Gu, Y.Z.; Huang, L.A.; Lu, J.X.; Wang, Z.Y. 1993: Treatment of acute promyelocytic leukemia with all-trans retinoic acid. a five-year experience Chinese Medical Journal 106(10): 743-748
Hemsworth, B.N. 1986: Haematological changes induced in the mouse by the isomers of dimethylmyleran and myleran Anticancer Research 6(5): 1133-1136
Pavlovsky, S. 1981: Argentinian Group for the Treatment of Acute Leukemia: our experience in the treatment of acute lymphoblastic leukemias Sangre 26(5b): 845-854
Sallan, S.E.; Clavell, L.A. 1984: Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: a 10-year experience Seminars in Oncology 11(4 Suppl 3: 19-21
Sun, G.L. 1993: Treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA): a report of five-year experience Zhonghua Zhong Liu Za Zhi 15(2): 125-129
Garay, G.; Aversa, L.A.; Svarch, E.; Sackmann Muriel, F.; Drelichman, G.; Santarelli, M.T.; Jiménez, E.; Divito, J.M.; Pavlovsky, S.; Eppinger Helft, M. 1989: Progress in the treatment of acute lymphoid leukemia in children. Experience of the GATLA/GLATHEM, 1967-1987 Sangre 34(2): 136-143
Del Potro, E.; Díaz Mediavilla, J.; Martínez, R.; Alvarez, A.; Krsnik, I.; Guerra, J.L.; Llorente, L.; López, J.C.; Díaz Morfa, M.; Villegas, A. 1989: Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols Medicina Clinica 92(16): 601-604
Head, D.R.; Kopecky, K.J.; Willman, C.; Appelbaum, F.R. 1994: Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience Leukemia 8(Suppl): S38-S41
Fukutani, H.; Naoe, T.; Ohno, R.; Yoshida, H.; Miyawaki, S.; Shimazaki, C.; Miyake, T.; Nakayama, Y.; Kobayashi, H.; Goto, S. 1995: Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. the Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho) Leukemia 9(9): 1478-1482
Himori, T.; Sugawara, N. 1972: Evaluation of antileukemic agents using transplantable rat leukemia induced by nitrosobutylurea (NBU) (DBLA-lines) as a screening tool: method of treatment of leukemia based on the results in experimental leukemia Nihon Rinsho. Japanese Journal of Clinical Medicine 30(4): 1051-1061
Zinzani, P.L.; Fiacchini, M.; Mazza, P.; Gherlinzoni, F.; Bocchia, M.; Tura, S. 1991: Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia Haematologica 76(4): 305-310
de Diego-Floreschapa, J.; López-Hernández, M.; Borbolla-Escoboza, J.R.; Trueba-Christy, E.; Carrillo-Rosales, T.; González-Avante, M. 1999: Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center Gaceta Medica de Mexico 135(3): 253-258
Oganov, R.G.; Gratsianskiĭ, N.A.; Mazur, N.A.; Lazebnik, L.B.; Belousov, I.B.; Sidorenko, B.A.; Ol'binskaia, L.I.; Vertkin, A.L.; Shevchenko, O.P.; Karpov, I.A. 1992: Circadian rhythm in the clinical course of cardiovascular diseases. Clinical experience using Norvasc (amlodipine) in the treatment of patients with ischemic heart disease and arterial hypertension Kardiologiia 32(5): 99-112
Alsabti, E.A.; Taleb, A.M.; Raji, H.M.; Kalil, O.Z.; Saleh, K.A. 1979: Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia Japanese Journal of Experimental Medicine 49(3): 157-168
Flandrin, G.; Daniel, M.T.; Fourcade, M.; Chelloul, N. 1973: Hairy cell leukemia (tricholeukocyte leukemia). Clinical and cytological Nouvelle Revue Francaise d'Hematologie 13(5): 609-640
Razboinikov, S.; Shipkov, T. 1973: Clinical experience in the treatment of hyperlipoproteinemia Vutreshni Bolesti 12(5): 114-121
Tsuda, S.; Nishigaki, H.; Okuda, T.; Horiike, S.; Yokota, S.; Yashige, H.; Taniwaki, M.; Misawa, S.; Takino, T.; Inazawa, J. 1988: Clinical evaluation of a combination treatment with cefmenoxime and cefsulodin of severe infections in leukemia and related disorders Japanese Journal of Antibiotics 41(5): 577-587
Philpott, M.G. 1970: The treatment of enuresis; further clinical experience with imipramine British Journal of Clinical Practice 24(8): 327-329